1. Sharma, Shikhar, Chung, Chi-Yeh, Uryu, Sean, Visvader, Jane E, Paul, Thomas A. 2023. Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer. In Cell chemical biology, 30, 1191-1210.e20. doi:10.1016/j.chembiol.2023.07.005. https://pubmed.ncbi.nlm.nih.gov/37557181/
2. Bergamasco, Maria I, Ranathunga, Nishika, Abeysekera, Waruni, Voss, Anne K, Thomas, Tim. 2024. The histone acetyltransferase KAT6B is required for hematopoietic stem cell development and function. In Stem cell reports, 19, 469-485. doi:10.1016/j.stemcr.2024.02.005. https://pubmed.ncbi.nlm.nih.gov/38518784/
3. Baell, Jonathan B, Leaver, David J, Hermans, Stefan J, Voss, Anne K, Thomas, Tim. 2018. Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth. In Nature, 560, 253-257. doi:10.1038/s41586-018-0387-5. https://pubmed.ncbi.nlm.nih.gov/30069049/
4. Bergamasco, Maria I, Vanyai, Hannah K, Garnham, Alexandra L, Thomas, Tim, Voss, Anne K. 2024. Increasing histone acetylation improves sociability and restores learning and memory in KAT6B-haploinsufficient mice. In The Journal of clinical investigation, 134, . doi:10.1172/JCI167672. https://pubmed.ncbi.nlm.nih.gov/38557491/